Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells
Authors:
- 22 June 2018
- journal article
- research article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 35 (1) , 49-62
Abstract
3,4-Methylenedioxypyrovalerone (MDPV), one of the most commonly abused synthetic cathinones, has caused several intoxications and deaths despite its short presence on the market. Apart from its effects on the monoamine systems in the brain, recent in vitro investigations have revealed cytotoxicity. In this study, the effects of increasing concentrations (10–1000 μM) of 3,4-Catechol-PV, one of major MDPV metabolites, on cell viability, morphology, and apoptosis have been evaluated after acute exposure (24–48 h) in human neuroblastoma SH-SY5Y cells—undifferentiated and differentiated to a more mature neuronal-like phenotype. Results indicated the following: (i) Cell viability: concentration-dependent decrease (15–55%) in differentiated SH-SY5Y after 24 h, with no exacerbation after 48 h (LC50 values 1028 and 951 μM, respectively); marked concentration-dependent decrease after 48 h (20–63%) in undifferentiated SH-SY5Y (LC50 553.9 μM) with mild effect (18–22% cell death) after 24 h at ≥ 500 μM only; the lowest toxic concentrations were 500 and 100 μM after 24 h, for undifferentiated and differentiated SH-SY5Y, respectively, and 10 μM after 48 h. (ii) Concentration- and time-dependent alterations of cell morphology in both SH-SY5Y types characterized by several intracellular cytoplasmic vesicles (undifferentiated more susceptible (effect at ≥ 50 μM) than differentiated cells (effect at ≥ 100 μM)), loss of the typical cell shape, neurite retraction, and cell density decrease. (iii) Activation of caspase-3 enzyme in differentiated and undifferentiated cells after 48 h. These findings suggest the potential involvement of 3,4-Catechol-PV in MDPV-induced neurotoxicity and support the use of this human cellular model as a species-specific in vitro tool to clarify the neurotoxicity mechanisms of synthetic cathinones and metabolites.Keywords
This publication has 53 references indexed in Scilit:
- Cytochrome P450–mediated drug metabolism in the brainJournal of Psychiatry and Neuroscience, 2013
- Cytochrome P450 enzymes in the brain: emerging evidence of biological significanceTrends in Pharmacological Sciences, 2011
- Studies on the metabolism of the α‐pyrrolidinophenone designer drug methylenedioxy‐pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC–MS and LC–high‐resolution MS and its detectability in urine by GC–MSJournal of Mass Spectrometry, 2010
- Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MPDV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time‐of‐flight mass spectrometryRapid Communications in Mass Spectrometry, 2010
- Nrf2 promotes neuronal cell differentiationFree Radical Biology and Medicine, 2009
- Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone‐induced Parkinson's disease modelsJournal of Neuroscience Research, 2008
- 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) Analogues: A Promising Class of Monoamine Uptake InhibitorsJournal of Medicinal Chemistry, 2006
- Nestin Expression in GangliogliomaExperimental Neurology, 2002
- Regional and cellular distribution of CYP2D subfamily members in rat brainXenobiotica, 2000
- The expression and posttranslational modification of a neuron‐specific β‐tubulin isotype during chick embryogenesisCell Motility, 1990